News · Vaccine
310 stories
2dMerck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
4dSTAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
6dOpinion: AAP president: How pediatricians are navigating federal leaders’ fearmongering on vaccines